Posts by: Santiago Gisler

Santiago Gisler

March 20, 2019March 20, 2019

Early Viral Infections in CF Infants Associated with Lung Inflammation, Bacterial Infections, Study Finds

cystic fibrosis

Early viral infections cause inflammation and bacterial infections in the lower airway of the lungs of infants with cystic fibrosis (CF), according to a study. The prospective study, “Early ... Read more

February 21, 2019February 21, 2019

NIH Funds Fight Against CF-associated Antibiotic Resistant Bacteria

cystic fibrosis

Researchers at Case Western Reserve University School of Medicine have received a $3.34 million grant from the National Institutes of Health (NIH) to develop a new strategy to sensitize Burkholderia ... Read more

February 19, 2019February 28, 2019

Hyperbaric Oxygen Treatment May Make Antiobiotics More Effective Against P. aeruginosa Infections, Study Says

cystic fibrosis, News

Exposing cystic fibrosis (CF) patients to high levels of oxygen through hyperbaric oxygen treatment may make Pseudomonas aeruginosa bacterial aggregates more sensitive to antibiotics like tobramycin and easier to eradicate from the lungs, a ... Read more

February 7, 2019February 7, 2019

Research Partners Work to Simplify, Improve Assessment of Lungs for Transplant

cystic fibrosis, News

SQI Diagnostics announced two new research agreements with research hospital University Health Network (UHN), Toronto, Canada, to simplify the assessment of lungs for transplant. By creating and licensing multiplexed protein ... Read more

January 30, 2019February 4, 2019

Link Found Between P. aeruginosa Infection and Disease Severity in CF Patients, Study Reports

cystic fibrosis, News

Patients with cystic fibrosis (CF) whose lungs have never been colonized by the Pseudomonas aeruginosa bacterium have a milder form of the disease, a retrospective study based on registry data suggests. ... Read more

January 17, 2019January 24, 2019

Phase 2 Trial Testing SPI-1005 for Ototoxicity in CF Patients Moving Forward

cystic fibrosis, News

Sound Pharmaceuticals (SPI) has enrolled its first-patient-in — meaning the first subject meeting the criteria for inclusion and exclusion of a clinical study — in a Phase 2 trial ... Read more

December 21, 2018December 21, 2018

AzurRx Starts Phase 2 Clinical Trial Testing MS1819-SD in CF Patients With EPI

cystic fibrosis, News

AzurRx BioPharma announced it has started a Phase 2 clinical trial testing the safety, tolerability, and efficacy of MS1819 Spray Dried (MS1819-SD) therapy in cystic fibrosis (CF) patients with ... Read more

December 20, 2018December 20, 2018

Gene Expression Patterns in Blood May Lead to Patient-tailored CF Treatment, Study Finds

cystic fibrosis, News

Researchers tested blood samples from cystic fibrosis (CF) patients and identified distinct gene expression patterns that could lead to patient-tailored treatments, a study reports. The study, “Identification of molecular ... Read more

December 19, 2018December 19, 2018

CFF Aids Development of NO-based Therapy, BIOC51, for Resistant Bacteria, Vast Therapeutics Says

cystic fibrosis, News

Vast Therapeutics announced that it received funding from the Cystic Fibrosis Foundation (CFF) to support further development of BIOC51, the company’s investigative treatment for antibiotic-resistant bacteria, including Pseudomonas aeruginosa, that is often ... Read more

December 11, 2018December 11, 2018

Higher Interleukin-7 Serum Levels Could be Biomarker for CF, Study Suggests

cystic fibrosis, News

A recent study confirmed the presence of increased serum levels of interleukin-7 (IL-7) in cystic fibrosis (CF) patients, compared with healthy controls. The researchers could establish a link between ... Read more

Pin It on Pinterest